Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of BLS-11 vs Tecfidera in Healthy Subjects
NCT04570670Phase 1Completed
- Sponsor
- Banner Life Sciences
- Start
- Jan 2017
- Primary completion
- Feb 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of monomethyl fumarate in multiple sclerosis (MS) (2 arms), sponsored by Banner Life Sciences. Primary endpoints: Area Under the Curve from Time 0 to Infinity at 24 hours and Maximum Plasma Concentration at 24 hours. Started Jan 2017; status: completed.
02
Drugs
monomethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04570670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04570670.